tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KNTE

Kinnate Biopharma’s Strategic Shift and Corporate Evolution
Company AnnouncementsKinnate Biopharma’s Strategic Shift and Corporate Evolution
23d ago
8K
KNTE
Xoma announces closing of tender offer
PremiumThe Fly
Xoma announces closing of tender offer
23d ago
KNTE
XOMA
KNTE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KNTE Earnings this Week: How Will it Perform?
1M ago
KNTE
Kinnate Biopharma Strikes Major Deal on Drug Rights
PremiumCompany Announcements
Kinnate Biopharma Strikes Major Deal on Drug Rights
2M ago
8K
KNTE
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
PremiumPress Releases
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
2M ago
KNTE
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
PremiumPress ReleasesKinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
2M ago
KNTE
Kinnate Biopharma sells exarafenib to Pierre Fabre Laboratories
PremiumThe Fly
Kinnate Biopharma sells exarafenib to Pierre Fabre Laboratories
2M ago
KNTE
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
PremiumPress Releases
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
2M ago
KNTE
Kinnate Biopharma sells exarafenib to Pierre Fabre Laboratories
PremiumThe Fly
Kinnate Biopharma sells exarafenib to Pierre Fabre Laboratories
2M ago
KNTE
Kinnate Biopharma price target raised to $2.59 from $1.50 at Stifel
PremiumThe Fly
Kinnate Biopharma price target raised to $2.59 from $1.50 at Stifel
2M ago
KNTE
XOMA
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DFS, COF, KNTE
PremiumPress Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DFS, COF, KNTE
2M ago
COF
DFS
Kinnate Biopharma downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Kinnate Biopharma downgraded to Market Perform from Outperform at William Blair
2M ago
KNTE
Xoma acquisition boosts royalty growth potential, says H.C. Wainwright
PremiumThe FlyXoma acquisition boosts royalty growth potential, says H.C. Wainwright
2M ago
KNTE
XOMA
Kinnate Biopharma’s Strategic Merger with XOMA for Cancer Innovation
PremiumCompany Announcements
Kinnate Biopharma’s Strategic Merger with XOMA for Cancer Innovation
2M ago
8K
KNTE
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
PremiumPress Releases
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
2M ago
KNTE
Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR
PremiumThe Fly
Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR
2M ago
KNTE
XOMA
Xoma to acquire Kinnate Biopharma for between $2.3352-$2.5879 per share plus CVR
PremiumThe Fly
Xoma to acquire Kinnate Biopharma for between $2.3352-$2.5879 per share plus CVR
2M ago
KNTE
XOMA
Pyxis Oncology announces appointment of Kobayashi as CMO
PremiumThe Fly
Pyxis Oncology announces appointment of Kobayashi as CMO
5M ago
KNTE
PYXS
Kinnate Biopharma reports Q3 EPS (65c), consensus (67c)
PremiumThe Fly
Kinnate Biopharma reports Q3 EPS (65c), consensus (67c)
6M ago
KNTE
Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
PremiumPress ReleasesKinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
6M ago
KNTE
Dell upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Dell upgraded, Starbucks downgraded: Wall Street’s top analyst calls
7M ago
DE
DQ
Kinnate Biopharma downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Kinnate Biopharma downgraded to Neutral from Outperform at Wedbush
7M ago
KNTE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >